Monophasic formulations contain only stabilized hyaluronic acid, which provides consistency, flexibility, and more uniform spreading. The hyaluronic acid is cross-linked in a single step. Revitrane uses a technique called Cohesive Polydensified Matrix (CPMCPM), resulting in a gel with heterogeneous cross-linking and lower molecular weight and viscosity compared to other fillers. These properties allow for a more even distribution of the material within the skin, making it easier to inject and mold. The unique technology of double cross-linking hyaluronic acid at low temperatures for an extended period results in the maximum combination of hyaluronic acid molecules, ensuring safety and stability.